Oct 31 |
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
|
Oct 31 |
Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
|
Oct 31 |
Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript
|
Oct 31 |
Amgen Inc. 2024 Q3 - Results - Earnings Call Presentation
|
Oct 31 |
Amgen (AMGN) Q3 2024 Earnings Call Transcript
|
Oct 30 |
Amgen updates 2024 guidance with revenue and EPS ranges including consensus
|
Oct 30 |
Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics
|
Oct 30 |
Amgen (AMGN) Beats Q3 Earnings Estimates
|
Oct 30 |
Amgen in charts: Prolia, XGEVA sales gain, while Enbrel continues to wind down in Q3
|
Oct 30 |
Amgen: Q3 Earnings Snapshot
|